Food and Drug Administration, et al., Petitioners v. Alliance for Hippocratic Medicine, et al.

  1. January 12, 2024

    Va. Abortion Drug Access Suit Paused For High Court Rulings

    A Virginia federal judge overseeing an abortion providers' suit seeking to prevent the U.S. Food and Drug Administration from revoking access to a long-approved and widely used abortion medication agreed on Friday to stay the proceedings until after the U.S. Supreme Court issues rulings in two cases that bear on the question. 

  2. January 08, 2024

    Supreme Court Is Suddenly Embroiled In A Term For The Ages

    When 2024 began, the U.S. Supreme Court's docket — spanning abortion, guns, social media, the modern regulatory system and more — already seemed certain to shake up the nation's cultural and economic landscapes. But now there's also a showdown involving Donald Trump and America's constitutional bedrock, auguring a truly tectonic term.

  3. January 01, 2024

    5 Supreme Court Cases To Watch This Spring

    "Blockbuster," "momentous" and "historic" are all words that have been used to describe the U.S. Supreme Court's current term as the justices prepare for a spring docket jam-packed with questions over the level of deference courts should give federal agencies, whether and how social media companies should be regulated and whether government efforts to combat misinformation crosses the line between persuasion and coercion.

  4. January 01, 2024

    Appellate Outlook: Circuit Splits & Hot Topics To Track In 2024

    The 2024 appellate almanac is looking lively after eye-popping opinions and arguments in 2023's homestretch. As the new year begins, several circuit splits seem more serious, ideological imbalances are in the spotlight, and luminaries of the U.S. Supreme Court bar are locked in a burgeoning battle over alleged corporate complicity in terrorism.

  5. December 13, 2023

    Supreme Court To Consider Fight Over Abortion Medication

    The U.S. Supreme Court said Wednesday that it would review a dispute over the abortion medication mifepristone, setting up a high court battle over a lower court judge's extraordinary decision to block the U.S. Food and Drug Administration's decades-old approval of the drug.

  6. December 09, 2023

    Circuit-By-Circuit Guide To 2023's Most Memorable Moments

    A former BigLaw partner in his 30s made history by joining a preeminent circuit court, a former BigLaw partner in his 50s made waves by leaving the largest circuit, and a former chemist in her 90s made enemies by resisting a probe on the most specialized circuit. That's a small sample of the intrigue that flourished in 2023 throughout the federal appellate system, where diversity bloomed and controversy abounded.

  7. November 22, 2023

    Mifepristone Ruling Risks 'Profound Disruption,' Justices Told

    The U.S. Food and Drug Administration told the U.S. Supreme Court that a Fifth Circuit decision limiting access to the abortion medication mifepristone could create "profound disruption" for patients and medical professionals, joining a distributor of the drug in urging the justices to review the "unprecedented" decision.

  8. November 16, 2023

    Anti-Abortion Lawmakers Urge Justices To Skip Pill Ruling

    A strong showing for abortion rights on Election Day did not dissuade 109 GOP lawmakers from asking the U.S. Supreme Court to pass on reviewing a Fifth Circuit decision that would curb access to the abortion drug mifepristone.

  9. November 08, 2023

    Justices Told To Ignore Group's Take On Abortion Pill OK

    The federal government and a distributor of the abortion pill mifepristone urged the U.S. Supreme Court to reject an organization's argument over its challenge to the U.S. Food and Drug Administration's approval of the medication, saying that millions of women have used it to safely terminate pregnancies.

  10. October 17, 2023

    Abortion Foes Ask For Full Review Or Nothing In Drug Appeal

    Anti-abortion activists are telling the U.S. Supreme Court that if the justices review parts of a Fifth Circuit ruling reinstating the approval of an abortion medication, they should consider the entire case.